This article was produced by Aegon Asset Management as part of their valued industry partnership with Insurance Investor.
Recent changes to the Solvency II framework have strengthened the case for insurer investment in securitisations. However, the benefits of securitisations extend well beyond capital relief. They can play a valuable role in improving diversification, enhancing risk-adjusted returns and strengthening overall portfolio construction.
Asset-Backed Securities (ABS) and Collateralised Loan Obligations (CLOs) provide exposure to areas of the economy that are often underrepresented in traditional insurance portfolios, including consumer lending, residential mortgages, SME financing and leveraged loans. This broader exposure can help insurers diversify their sources of risk while maintaining access to liquid, publicly traded investments.
For many insurers, the floating-rate nature of securitisations is particularly attractive in today's market environment. Unlike many traditional fixed-income assets, ABS and CLOs typically have limited interest-rate sensitivity, enabling investors to access additional spread without taking significant duration risk. This characteristic can be especially valuable for non-life insurers seeking to reduce asset-liability mismatches while enhancing portfolio income.
Life insurers can also benefit from securitisations through increased diversification and access to additional spread opportunities with relatively modest interest-rate sensitivity. At the portfolio level, securitisations may help improve risk-return characteristics while providing exposure to underlying economic activity such as housing, consumer finance and business lending.
The revised Solvency II framework has further improved the attractiveness of certain investment-grade securitisation strategies by reducing capital requirements. Combined with their diversification benefits and return potential, this creates a compelling case for insurers to reassess the role of securitisations within strategic asset allocations.
Governance remains a major qualitative consideration. Successful implementation requires expertise in collateral analysis, structural protections, reporting quality, and Solvency II look-through requirements. In practice, this means the case for securitisations is strongest where the insurer has either internal structured-credit capabilities or access to a manager that can provide transparent ongoing analytics and regulatory support.
Securitisations offer insurers an opportunity to enhance portfolio construction through greater diversification, additional spread and attractive risk-adjusted return potential. Combined with the benefits of the revised Solvency II framework, ABS and CLOs can support stronger portfolio resilience and contribute to long-term investment outcomes.
Sign in to read the full article or Register for FREE and get access
SIGN IN
FREE PREMIUM ACCOUNT
Don't have an account yet?
To access
the premium content FOR FREE on Insurance Investor, you must first sign in to your account.
Not subscribed? Sign up today for free
Why subscribe? Click here for more details